Potentiation of gastric ulceration by experimental lead exposure in rats

Journal of Biological Sciences

Volumn 6, Issue 3, 2006, Pages 480-484

  Olaleye, S B ^a   Raji, Y ^a   Onasanwo, S A ^a   Erigbali, P ^a   Oyesola, S O ^a   Odukanmi, A ^a   Omotosho, I O ^a   Elegbe, R A ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Gastric; Lead toxicity; Rats; Ulcer

Indexed keywords

ALCOHOL; CHLORIDE; INDOMETACIN; LEAD;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPOTHERMIA; IMMOBILIZATION STRESS; LONG TERM EXPOSURE; MALE; NONHUMAN; RAT; STOMACH JUICE; STOMACH LESION; STOMACH PH; STOMACH SECRETION; STOMACH ULCER;

ANIMALIA;

EID: 33745757376     PISSN: 17273048     EISSN: 18125719     Source Type: Journal    
DOI: 10.3923/jbs.2006.480.484     Document Type: Article

References (21)

1. Al-Saleh Iman, A.S.A., 1999. Biochemical and clinical consequences of lead poisoning. Med. Res. Rev., 14: 795-854.
2. Anadan, R., R.D. Rekha, N. Saravanan and T. Devaki, 1999. Protective effects of Picrorrhiza kurroa against HCl/ethanol induced ulceration in rats. Fitoterapia, 70: 498-503.
3. Anetor, J.I., F.A.A Adeniyi and S.B. Olaleye, 2003. Molecular epidemiology: A better approach for the early detection of pathophysiologic response to environmental toxicants and disease. Afr. J. Biomed. Res., 6: 113-118.
4. Brodie, D.A., 1966. Drug effects on gastric secretion and stress gastric hemorrhage in the rat. Digestive Dis., 15: 111-120.
5. Cho, C.H. and C.W. Ogle, 1978. Does increased gastric mucus play a role in the ulcer-protecting effects of zinc sulphate? Experientia, 34:90-91.
6. Corne, S.J, S.M. Morrissey, R.J. and Woods, 1974. A method for the quantitative estimation of gastric barrier mucous. J. Physiol., 242: 116P-117P.
7. Desai, J.K., R.K. Goal and N.S. Parmar, 1997. Pathogenesis of peptic ulcer disease and current trends in therapy. Indian J. Physiol. Pharmacol., 41: 3-15.
8. Elegbe, R.A and S.O.A. Bamgbose, 1976a. Protective dietary factors in experimental ulceration-study of some Nigerian cereal and tubers. Postgrad. Med. J., 52: 258-263.
9. Elegbe, R.A. and S.O.A. Bamigbose, 1976b. The antihistaminic properties of 1-methy-3 pyroldy phenylclohexane glycolate methobromide Arch. Biochem. Exp. Biol., 12: 329-332.
10. Goyer, R.A. and B.C. Rhyne, 1973. Pathological effects of lead. Intl. Rev. Exp. Pathol., 12: 1-77.
11. Ibironke, G.F., S.B. Olaleye, O. Balogun and D.A. Aremu, 1997. Antiulcerogenic effects of diets containing seeds q Garcinia kola (Heckel) Phytotherapy Research., 11: 312-313.
12. Johnson, H.D., 1967. The pathogenesis of peptic ulcers. Lancet, 518-520.
13. Lowry, O.H., N.J. Rosenborough, A.L. Farr and R.J. Randal, 1951. Protein measurement with the Folin phenol reagent. J. Biol Chem., 193: 265-275.
14. Oberly, T.D., A.L. Friedman, R. Moser and F.L. Siegel, 1995. Effects of lead administration on developing rat kidney II; functional, morphological and immunochemical studies. Toxicol. Applied Pharmacol., 131: 94-107.
15. Rao, V.N., F.A. Santos, T.T. Sobrierra, M.F. Souza, C.L. Melo and E.R. Silveira, 1997. lnvestigations on the gastroprotective and antidiarrhoeal properties of Ternatin, a tetramethoxy flavone from Egletes viscose. Planta. Med, 63: 146-149.
16. Ronis, M.J., J. Aronson, G.G. Gao, W. Hogue, R.A. Skinner, T.M. Badger and C.K. Lumpkin, 2001. Skeletal effects of developmental lead exposure in rats. Toxicol. Sci., 62: 321-329.
17. Sato, T., M. Imamura, I. Sasaki and A. Ohned, 1985. Gastric acid secretion and Gastrin and Gastric Inhibitory polypeptide release in cirrhosis patients Am. J. Gastroenterol., 80: 163-169.
18. Schroeder, H.A. and I.H. Tipton, 1968. The human body burden of lead. Arch. Environ. Health, 17: 965-978.
19. Soll, A.H., 1990. Pathogenesis of peptic ulcer and implication for therapy. New Engl. J. Med., 322: 909-916.
20. Stowe, H.D., R.A. Goyer, M.M. Kigman, M. Wilson and M. Cates, 1973. Experimental oral lead toxicity in young dogs; Clinical, and morphological effects. Arch. Pathol., 95: 106-116.
21. Vane, J.R., 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (New Biol.), 231: 232-235.